The United States authorities pays vaccine producer Moderna $176 million to develop a brand new mRNA vaccine to deal with fowl flu.
The U.S. Division of Well being and Human Providers pays Moderna $176 million for a vaccine containing the identical mRNA know-how as the corporate’s COVID-19 vaccine.
Chicken flu, or H5N1, has been reported in dairy cows and has contaminated three individuals in the USA.
In whole, 135 dairy herds have been contaminated with fowl flu in 12 states.
BREAKING: The U.S. pays vaccine maker Moderna $176 million to develop a pandemic vaccine that may very well be used to deal with fowl flu in individuals. https://t.co/TTbPScukYd
— The Related Press (@AP) July 2, 2024
Per AP:
The U.S. authorities pays the vaccine maker Moderna $176 million to develop a pandemic vaccine that may very well be used to deal with fowl flu in individuals as circumstances in dairy cows proceed to mount throughout the nation, federal officers introduced Tuesday.
The funds are focused for launch by way of the U.S. Division of Well being and Human Providers and pays for continued growth of a vaccine that makes use of the identical mRNA know-how that allowed speedy growth and rollout of vaccines to guard in opposition to COVID-19. The award was made by way of the Biomedical Superior Analysis and Improvement Authority, or BARDA, a program specializing in medical remedies for potential pandemics.
Moderna will launch trials to check the security and effectiveness of a vaccine that may very well be used to scale up a response to a fowl flu pandemic if wanted.
The H5N1 virus was detected earlier this 12 months in dairy cows and has unfold to greater than 135 herds in 12 states and contaminated three individuals so far, all with gentle circumstances. Federal well being officers stress that the chance to the broader inhabitants stays low.
Final month, The Gateway Pundit reported on the World Well being Group’s warning to the worldwide neighborhood a few new pressure of fowl flu.
READ: